There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Data availability:

ScienceOpen disciplines: Oncology & Radiotherapy, Medicine

Comments

Comment on this article

Cited by 2

New developments in the management of non-small-cell lung cancer, focus on rociletinib: what went wrong?
Authors: Nele Van Der Steen, Chiara Caparello, Christian Rolfo …
Treatment Paradigms for Advanced Non‐Small Cell Lung Cancer at Academic Medical Centers: Involvement in Clinical Trial Endpoint Design
Authors: Charu Aggarwal, Hossein Borghaei

See all cited by

AZD9291, a mutant‐selective EGFR inhibitor, as first‐line treatment for EGFR mutation‐positive advanced non‐small cell lung cancer (NSCLC): Results from a phase 1 expansion cohort

Read this article at

Related collections

Karger: Oncology

Comments

Comment on this article

Similar content 1,700

Cited by 2